ArticleScientific reports2024

In silico ADMET profiling of Docetaxel and development of camel milk derived liposomes nanocarriers for sustained release of Docetaxel in triple negative breast cancer.

Kousain Kousar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.